DOCS - NYSE
Doximity, Inc.
$21.04
+1.2%Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
At a Glance
Live SnapshotDoximity, Inc. Profit Bridge
Profitability Analysis
Gross Margin
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating Margin
Outstanding operational efficiency. The company generates substantial profit from core operations.
Net Profit Margin
Exceptional profitability. The company converts a significant portion of revenue to bottom-line earnings.
Effective Tax Rate
Moderate tax rate typical for most corporations. Represents standard tax burden on profits.
Profitability Insight
Exceptional profitability across all levels: Strong pricing power, efficient operations, and healthy bottom line indicate a high-quality business with sustainable competitive advantages.
Doximity, Inc. Income Statement
DOCS • NYSE
| Doximity, Inc. Income Statement | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||
644.9M | 570.4M | 475.4M | 419.1M | 343.5M | 206.9M | 116.4M | 85.7M | |
GROSS PROFIT | ||||||||
(70.3M) | (55.9M) | (50.7M) | (53.5M) | (39.8M) | (31.2M) | (14.9M) | (10.9M) | |
574.5M | 514.5M | 424.8M | 365.6M | 303.8M | 175.7M | 101.5M | 74.8M | |
OPERATING INCOME | ||||||||
(359.6M) | (286.7M) | (260.9M) | (240.5M) | (190.2M) | (122.4M) | (79.3M) | (67.9M) | |
(228.9M) | (191.4M) | (171M) | (160.3M) | (127.9M) | (78.5M) | (46.9M) | (40.4M) | |
(130.7M) | (93M) | (82M) | (80.2M) | (62.4M) | (43.9M) | (32.4M) | (27.5M) | |
214.9M | 227.8M | 163.9M | 125.1M | 113.5M | 53.3M | 22.2M | 6.9M | |
PRE-TAX INCOME | ||||||||
0.0 | 35.9M | 21.7M | 9.3M | 2.1M | 301K | 1.5M | 1.1M | |
(0.0) | (2.3M) | (7.9M) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
35.1M | 35.8M | 21.3M | 8M | 469K | 4.5M | 1.4M | 1M | |
250M | 263.6M | 185.2M | 133.2M | 114M | 57.8M | 23.5M | 7.9M | |
NET INCOME | ||||||||
(54M) | (40.4M) | (37.6M) | (20.3M) | -40.8M | (7.6M) | -6.2M | (98K) | |
196.1M | 223.2M | 147.6M | 112.8M | 154.8M | 50.2M | 29.7M | 7.8M |
SEC Filings
DOCS - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-K 10-K 2026 FY FY | May 19, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 13, 2026 | May 13, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 17, 2026 | April 13, 2026 | 2026 | |
10-Q 10-Q 2025 Q4 Q4 | February 05, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 05, 2026 | February 03, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 30, 2025 | December 24, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 06, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 06, 2025 | November 06, 2025 | 2025 | |
8-K 8-K 2025 N/A | September 02, 2025 | August 28, 2025 | 2025 | |
8-K 8-K 2025 N/A | August 15, 2025 | August 13, 2025 | 2025 |
Related Guides
Continue your DOCS research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.